Marijuana Stocks Premium

marijuana stocks

We at Marijuana Stocks wanted to give an update to our Connect the Dots report we put out yesterday, but first we need to give you some very important information!

Cannabis Wheaton (KWFLF) (CBW.V) has brought on syndicate agents including Canaccord Genuity Corp & Eight Capital to raise more than $50M CAD for their Cannabis Streaming business model. This raise will set the bar for other Canadian firms as it will represent one of the single largest capital raises in the history of the cannabis industry, that is not directly focused on cultivating. With this, Cannabis Wheaton is now heavily cashed up and one would hope that means management will begin aggressively working towards securing accretive deals that create value for shareholders and expand their overall reach.

First and foremost, we can only speculate what the company’s plans are with proceeds raised with regards to specific direct investment, but we expect to see the company use this capital to sign a new streaming partnership agreement with one of Canada’s major cultivators. We will continue to monitor the situation closely and provide updates as we get them. Now, let’s discuss what happened with trading on Tuesday, May 23, 2017.

In the pre-market hours, Cannabis Wheaton announced a private placement in the amount of $50,000,000 CAD which we referenced above as a truly a monster raise. Pending that news and at the company’s request, the Canadian exchange halted trading for the announcement of the news. FINRA then also issued a code U1 halt in the U.S. (that is NOT an SEC regulatory halt). This type of halt refers to a stock that is listed on a foreign exchange and gets halted by that exchange (in this case Canada) so FINRA must then also halt trading in the duel listing in the U.S.. This means no one could buy or sell shares of Wheaton until 3:15pm EST when the Canadian exchange and FINRA lifted the temporary halt and trading resumed.

The price of the stock adjusted for the financing news and opened for trade at $1.04 on the U.S. side. This is a nice discount compared to where the stock was trading prior to the news considering the stock had recently made a huge move on Monday after trading €4.9 million on the German exchange and $7.4 million CAD with Cannabis Wheaton (OTC KWFLF) (TSX CBW.V) gaining nearly 138% in the 3 days prior to the financing news. We expect the market to begin reflecting the opportunity for Cannabis Wheaton Corp. as their business model is cutting edge and their CEO Chuck Rifici has a proven record within the cannabis industry.


Pursuant to an agreement between MAPH and Cannabis Wheaton (KWFLF) we were hired for 30 Days to publicly disseminate information about (KWFLF) including on the Website and other media including Facebook and Twitter. We are being paid $150,000 (CASH) for and were paid “0” shares of restricted common shares of Cannabis Wheaton. We may buy or sell additional shares of (KWFLF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

marijuana-stocks-canadian-canada

Canadian cannabis stocks continue to attract new investors, new institutional capital, and new strategic partners as legal recreational cannabis will help the industry see incremental growth for years to come.

Although this week is a short week due to the Monday’s holiday, Canadian firms continue to report significant company developments and we want to highlight three stories that investors need to be aware of. 

Tetra Enters Strategic Partnership and Changes its U.S. Symbol

Tetra Bio-Pharma (TBP.CN: CSE) (TBPMF) signed a definitive agreement with Panag Pharma for the development and commercialization of novel cannabinoid based formulations for the treatment of pain and inflammation. This partnership combined with the company’s patent filing last week could make this a profitable relationship. Tetra is focused on generating revenue in 2017 by launching retail products via its partnership with Panag.

Under the agreement, Tetra will have the exclusive right to sell the ocular and topical drug products in North America with right of first negotiation for international markets. Tetra will also have a right of first negotiation for future cannabinoid-based products.

Tetra will work with Panag’s team to ensure a rapid and successful process leading to marketing authorization. Panag will continue to develop new novel products for unmet medical need and Tetra will focus on commercializing these products.

Panag has developed potential new cannabinoid-based therapies for ocular and topical anti-inflammatory and pain markets. The company also developed a cannabinoid topical drug product for the local treatment of pain and inflammation.

Tetra also issued a corporate update and highlighted the following:

  • Changed its U.S. OTCQB symbol to TBPMF
  • Issued 501,800 new shares as part as of a service agreement from June 20, 2016.
  • Issued 250,000 new shares as part of a service agreement with MAPH Enterprises to broaden U.S. investor awareness.

 Canadian Biotech Firm to Raise $5+ Million

InMed Pharmaceuticals (IN.CN: CSE) (IMLFF) entered an underwriting agreement with a syndicate of underwriters led by Canaccord Genuity and includes Eight Capital along with Roth Capital Partners (placement agent). The underwriters agreed to purchase, on an underwritten basis, 11,120,000 units at $0.45 each for $5 million in aggregate gross proceeds.

InMed plans to use the proceeds for the following reasons: 1) To support the continued research and development of INM-750 for the treatment of Epidermolysis Bullosa, 2) To further develop the company’s other research and development programs including its biosynthesis assets, 3) For general and administrative expenses, and 4) To fund working capital.

Each unit is comprised of one common share and one-half share purchase warrant. The warrant has an exercise price of $0.65 and will be exercisable for a period of 24 months following the closing date. The offering is expected to close by May 30th. InMed granted the underwriters the option to purchase up to 1,668,000 additional units at $0.45 each for a period of up to 30 days after the closing date. If this option is exercised in full, the company will generate $5.75 million in aggregate gross proceeds.

Marapharm Looks to Enter Nevada’s Recreational Market

Yesterday, Marapharm Ventures (MDM: CSE) (MRPHF) took a significant step forward in its plans to take advantage of the Nevada recreational cannabis market. Marapharm acquired two fully equipped buildings that meet Nevada’s state licensing requirements and the company must move quick if they want to take advantage of this huge opportunity.

Marapharm’s buildings were inspected and given pre-approval for cultivation and processing. If the company can be approved before May 31st and conduct a taxable transaction, it will be allowed to apply for licensing under the state’s recreational program.

Nevada’s department of taxation is currently accepting applications for recreational cultivation, production, lab and retail store licenses, from existing Nevada marijuana establishments that hold valid registration certificates.

Marapharm has 300,000 square feet of medical marijuana licenses for its land and facilities in Washington state and Nevada. About three years ago, Marapharm applied in Canada to Health Canada and the application is currently in the in-depth screening process. In September, Health Canada contacted Marapharm with a provision to amend its application to allow for the new regulations, ACMPR.

We are on the sidelines but think this is a story and a stock investors should keep an eye on!

 

Author: Michael Berger

 


 

Disclaimer: Pursuant to an agreement between MAPH and InMedPharmaceuticals., we were hired for a period beginning February 24 2017 and ending April 24, 2017 to publicly disseminate information about (IMLFF) including on the Website and other media including Facebook and Twitter. We are being paid $40,000 (CASH) for and were paid “250,000” shares of restricted common shares of InMed Pharmaceuticals.We may buy or sell additional shares of (IMLFF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Pursuant to an agreement between MAPH and Tetra Bio-Pharma, we were hired for a period of 90 days to publicly disseminate information about (TBPMF) including on the Website and other media including Facebook and Twitter. We are being paid $75,000 (CASH) for and were paid 250,000 restricted common shares of Tetra Bio-Pharma. We may buy or sell additional shares of (TBPMF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

marijuana stocks

A Revolutionary Cannabis Investment?

Some of the greatest investment minds in the world say, “You invest in management.” And since the birth of MarijuanaStocks.com, few management personnel have shined brighter than Cannabis Wheaton Income Corp. CEO Chuck Rifici. Mr. Rifici has accomplished with Cannabis Wheaton something that no other cannabis industry CEO has. The business model he has implemented is something that we feel every marijuana investor MUST know about. Cannabis Wheaton (KWFLF)(CBW.V) provides a very unique opportunity for marijuana investors by greatly reducing risk while still maintaining tremendous upside potential.

But before we explain the Cannabis Wheaton business model and why we feel EVERY investor should know about it, let’s first take a look at Chuck Rifici. Because as we said earlier, “you invest in management.” And there may not be a more recognizable managerial figure who has done more for the marijuana industry than Mr. Rifici.

Invest in Management

Chuck Rifici is responsible for co-founding and taking public the largest full-scale producer of government-sanctioned marijuana as its CEO in April 2014; a company by the name of Tweed Inc. whose name later changed to Canopy Growth Corp. (TWMJF)(WEED.TO). To this day, Canopy Growth remains the largest public cannabis company with a staggering market cap of approximately $1Billion. In 2016, WEED hit $17.86 approximately 550% higher than the IPO price. It is widely agreed to be the most successful marijuana company to go public and is seen as the benchmark and leader of the industry.

Take a look at how WEED stock has performed over the last 2 years:

marijuana stocks

When considering an investment in any company, it’s important to look at the management team. Who is leading the ship? Is this their first rodeo? Or have they already proven successful in bringing a company to market that has built shareholder value? Well, Chuck Rifici’s track record with co-founding Tweed speaks for itself and gives Cannabis Wheaton shareholders confidence that they have a marijuana industry trailblazer leading their ship.

But Rifici’s resume is filled with much more than just Tweed. In 2011, Rifici was appointed CFO of the Liberal Party of Canada by interim party leader Bob Rae. In 2014, Rifici was also named to the Top Forty under 40 by Ottawa Business Journal, named Alumnus of the Year by the University of Ottawa Faculty of Engineering, and received the Exceptional New Business Award by the Ottawa Chamber of Commerce.

Rifici also sat on the Board of marijuana starlets Supreme Pharmaceuticals (SPRWF) (SL.CN), Aurora Cannabis (ACBFF) (ACB.V), and CannaRoyalty (CNNRF) (CRZ.V). These board positions helped Rifici keep his ear to the ground, expand his network, and gain insight to the marijuana industry in both Canada and the U.S. He actually just resigned from his Supreme Pharma and Aurora Cannabis Board seats because of a slight conflict of interest but mostly to focus all of his time and energy towards building Cannabis Wheaton into a revolutionary cannabis company.

Cannabis Wheaton’s Streaming Model—Revolutionizing Cannabis Investment

Cannabis Wheaton is the first company to bring a streaming business model to the marijuana industry. This unique model can greatly reduce risk for investors while maintaining tremendous upside potential from a booming industry. Streaming business models are normally found in the mining industry and refer to when a company strikes a deal with a miner to purchase all or part of its future metal production in exchange for upfront cash. Perhaps the most notable example is silver giant Silver Wheaton (NYSE: SLW). This works well because mining is a very cash intensive business and requires a lot of upfront capital. And the cannabis industry is about to undergo a massive expansion that will be an serious capital burden on current marijuana producers.

Rifici has said that the marijuana industry must increase total production by 10 times the current rate in order to keep pace with the increased demand for marijuana once the drug is legalized for recreational use. Producers are barely keeping up with cannabis demand from just medical marijuana users, never mind when legal recreational use goes into effect.

Currently, there is only 1.4 million square feet of licensed medical marijuana production facilities in Canada. According to Rifici, 14 million square feet is needed to satisfy the upcoming demand. Such a massive expansion is a major financial burden and carries great risk for companies trying to expand so much so quickly. And that is where the opportunity lies for Cannabis Wheaton.

“We’re going to see tremendous growth in the industry…There have been a lot of announced expansions that fill maybe a third of that gap. But there’s still 6 or 7 million square feet that needs to be built out,” said the Rifici.

Under the streaming model, Cannabis Wheaton will provide marijuana producers with the necessary capital to expand their operations in exchange for a minority equity stake in the company and a portion of their future production at an agreed upon discounted price. The company will also provide their partners with guidance and expertise on facility construction, cultivation, and the licensing process. Rifici has brought to Wheaton several of the early key members of Tweed including the top cannabis legal team in Canada that has helped half a dozen Licensed Producers (LPs) obtain their licenses.

Cannabis Wheaton has already signed 16 streaming deals with 14 partners across 6 different provinces of Canada. Their partners’ credentials include:

  • 2 sales licenses.
  • 3 cultivation licenses.
  • 4 affirmation letters.
  • 5 advanced pre-affirmation stage applicants.

Through these agreements, Cannabis Wheaton already has access to 1.3 million square feet of cultivation by 2019, 30,000 registered medical marijuana patients, and nearly 40 medical cannabis clinics.

One agreement we feel worth mentioning specifically is the company’s deal with Broken Coast Cannabis Ltd., a British Columbia based medical cannabis producer that has established itself as a top provider of high grade cannabis products. Broken Coast’s clean tech production methods and systems deliver consistent premium cannabis. The company was also recently awarded one of the few 18-month Access to Cannabis for Medical Purposes Regulation (ACMPR) licenses, which is a testament to its compliance record.

Broken Coast and its entities will utilize the experience and capital of Cannabis Wheaton to accelerate expansion and scale production in a short period of time. Under the terms of the agreement between the companies, Broken Coast will source a proposed site to complement their current site. The parties expect the new location to accommodate at least 100,000 square foot state-of-the-art cannabis cultivation facility.

Broken Coast will operate the new facility in accordance with its industry best practices and the two companies will share the proceeds with Cannabis Wheaton receiving 49% of the product output.

5 Reasons to Consider Cannabis Wheaton

  1. Licensed Producer Diversification- Because the company is working with such a wide range of cannabis cultivation companies and receiving both an equity stake in those companies and a percentage of the end product, shareholder risk is spread out amongst several companies rather than just one.
  2. Exposure to Tremendous Upside- Usually, reducing risk results in reduced potential reward, too. But not in this case. Even with the reduced risk, shareholders are exposed to the explosive industry expansion that Rifici explained as being a 10x expansion. Current cannabis revenue numbers in Canada will pale in comparison to what we see once legal recreational use goes in effect. Cannabis Wheaton will hold an equity stake in many producers as well as owning portions of the end product at a discounted price.
  3. Geographic Diversification- Cannabis Wheaton has signed agreements with partners across 6 different provinces in Canada. This brings exposure to several different markets and acts almost as a loophole for the company to take advantage of a few question marks the industry has regarding distribution.
  4. Proven Business Model- The streaming business model has already been proven successful for some of the largest metal miners in the world. Silver Wheaton, a streaming company with a market cap of approximately $10Billion, went to this model because they generally have a bullish outlook on the price of silver. So, it makes sense for them to fund a miner’s drilling operations and expansion to purchase the future metal output at a steep discount. Similarly, Rifici and Cannabis Wheaton have a bullish outlook on the production rate and revenue numbers for marijuana in Canada expecting a 10x expansion of the industry. So, it makes sense to help fund the expansion in return for equity ownership and a portion of the end product.
  5. Successful Management- The team behind Cannabis Wheaton has already taken the largest producer of government-sanctioned marijuana public. And it was and remains the most successful IPO in the cannabis space and true leader of the industry. 

Conclusion

Ever since Rifici co-founded Tweed and brought the cannabis juggernaut public in 2014, investors wondered what his next project would be. Rifici said he is proud of what he built with Tweed but was ready to put the past behind him.

“I’m essentially moving on to what I think are far better opportunities in the space,” said the Cannabis Wheaton CEO.

It’s hard to imagine what opportunities could be more successful than a $1Billion market cap, top marijuana producing, cannabis leader that gained 550% from its IPO. But if anyone knows an opportunity in the marijuana space when they see one it’s Chuck Rifici.

Licensed Producers are already having trouble keeping up with demand from about only 130,000 registered medical marijuana patients. When legal recreational use goes into effect, demand is going to skyrocket. The current 1.4 million square feet of cultivation facility space simply isn’t going to cut it. Not even close. The entire industry is racing to undergo a massive expansion that will see cultivation space increase by about 10 times. That type of expansion is extremely costly and carries great risk for individual producers.

However, with their streaming business model, Cannabis Wheaton is de-risking the expansion while still giving investors exposure to the booming industry growth. With 16 agreements already inked with 14 different partners across 6 different provinces, Cannabis Wheaton could very well be revolutionizing the way investors capitalize on the cannabis industry.

 


Disclaimer: Pursuant to an agreement between MAPH and Cannabis Wheaton (KWFLF) we were hired for 30 Days to publicly disseminate information about (KWFLF) including on the Website and other media including Facebook and Twitter. We are being paid $150,000 (CASH) for and were paid “0” shares of restricted common shares of Cannabis Wheaton. We may buy or sell additional shares of (KWFLF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

marijuana-stocks-canadian-cannabis-

The Canadian stock market was closed for Victoria Day yesterday and today, three marijuana stocks reported several significant developments. We have highlighted these developments below to help you focus on important trends sweeping the industry.

New Cannabis IPO to Raise $50+ Million

One of newest and most differentiated Canadian cannabis producers, Cannabis Wheaton (CBW.V: TSX Venture) (KWFLF) announced a $50 million private placement and engaged a syndicate of agents co-led by Eight Capital and Canaccord Genuity.

The firm is selling special warrants and convertible debenture units and will use the net proceeds for general corporate purposes, for the financing of its streaming partners pursuant its streaming agreements, and for general and administrative expenses.

Cannabis Wheaton is off to a great start after the company reported that MMCAP International Inc. SPC intends to subscribe for up to $20,000,000 of the offering. The offering is expected to occur on June 21st and the company granted the underwriters an over-allotment option which increases the offering to $57.5 million.

Cronos’ Breaks Ground on a Brand New 315,000 sq. ft. Facility

Today, Cronos Group’s (MJN.V: TSX Venture) (PRMCF) wholly-owned licensed producer, the Peace Naturals Project broke ground on a 315,000 sq. ft. expansion that includes a 286,000 sq. ft. production facility, a 28,000 sq. ft. greenhouse, and an additional 1,200 sq. ft. extraction lab.

Upon completion, the facility is expected to be the largest purpose-built indoor cannabis production facility in the world. The facility is expected to complete by November and fully operational by summer 2018. This expansion will bring Peace’s total estimated production capacity to 40,000 kg a year.

The facility is designed to GMP certification standards and will include:

  • An area for proprietary genetic breeding
  • Pharma lab for cannabinoid and terpene extraction, identification, and formulation
  • R&D space for analyzing metabolite enhancement and new lighting technologies
  • Tissue culture laboratory
  • Industrial-grade kitchen
  • Processing infrastructure that supports production from other facilities

Cronos is breaking ground on the greenhouse today and the facility will be used to collect data and implement advanced cultivation techniques that can be replicated at its other production facilities. The company’s extraction lab will augment capabilities in both purification and recombination of cannabinoid compounds to create innovative formulated products. The greenhouse and lab are expected by the end of the summer.

Aurora to Supply Resources to Support a Groundbreaking Legal Case

Today, the Canadians for Fair Access to Medical Marijuana (CFAMM) reported an investment by Aurora Cannabis (ACB.V) (ACBFF) that is of a different nature than its prior investments.

CFAMM announced that Aurora has committed financial and other resources to support Gordon Skinner’s defense in what might be a potentially precedent-setting medical cannabis insurance coverage case. CFAMM has been providing strategic support to Skinner and Aurora’s resources will ensure that Skinner can defend his case.

On January 30th, the Nova Scotia Human Rights Commission ruled that the Board of Trustees of the Canadian Elevator Industry Welfare Trust Fund committed discrimination by denying coverage for the medical cannabis Skinner uses to manage chronic pain and other conditions resulting from a work-related injury that left him permanently impaired. Following the decision, the Board of Trustees filed an appeal against Skinner and the Commission in the Nova Scotia Court of Appeal. The appeal has been set for October 2, 2017.

Founded in 2014, Canadians for Fair Access to Medical Marijuana (CFAMM) is a federal non-profit, patient-run organization dedicated to protecting and improving the rights of medical cannabis patients. CFAMM’s goal is to enable patients to obtain fair and safe access to medical cannabis with a special focus on affordability, including private and public insurance coverage.

We want to commend Aurora on its commitment to improving the cannabis industry and supporting patients in need. This decision may have a lasting impact on the sector and could change the landscape of the Canadian medical cannabis industry.

 


Disclaimer: Pursuant to an agreement between MAPH and Cannabis Wheaton (KWFLF) we were hired for 30 Days to publicly disseminate information about (KWFLF) including on the Website and other media including Facebook and Twitter. We are being paid $150,000 (CASH) for and were paid “0” shares of restricted common shares of Cannabis Wheaton. We may buy or sell additional shares of (KWFLF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

marijuana_stocks

The legal marijuana industry is the fastest growing industry in the world and investors are frequently trying to learn how to invest in marijuana stocks. Over the last two years, the industry has exploded and now medical cannabis is legal in Australia, Germany, Canada, Uruguay, Colombia, and the Netherlands.

The rapid growth of the legal marijuana industry has led to a surge in the number of opportunities and only here, can you access the best information and learn how to invest in marijuana stocks and capitalize on this incredible industry.

The legal marijuana industry offers immense upside but investors still need to be selective with their investments. This new growth industry is exciting but investors need to educate themselves and learn how to invest in marijuana stocks before doing so.

How Do I Invest in Marijuana Stocks?

While it may sound complicated, it is actually very easy to open a brokerage account began buying and selling stock. The easiest and cheapest way to start investing is by opening an online brokerage account. Here are some of the most common online brokerages:

  • E-trade: www.etrade.com
  • Interactive Brokers- www.InteractiveBrokers.com
  • Merrill Edge – www.MerrillEdge.com
  • Scottrade- www.Scottrade.com/Brokerage

Access the best information for free today by signing up for the MarijuanaStocks.com newsletter.

 

 

0 705

Dr. Sue Sisley, a psychiatrist and at one time a clinical assistant professor at Arizona University (AU), is one of the nation’s leading scientific experts on medical marijuana.

Despite her never serving in the arm forces Sisley wears or at times carries a dog tag stamped with the number “22,” as a constant reminder of how many American vets commit suicide each day—which a majority of them are suffering from post-traumatic stress disorder, according to data from the Department of Veterans Affairs.

“Even though we all realize that is a falsely low number… it is a horrific number,” Sisley said to NewsMax Health, stating that veteran suicides outnumber the national civilian average by a large number.

After leaving AU, where she received her medical degree, Sisley finally was able to gain approval from the government to commence investigative research on cannabis for PTSD.

Currently, she has teamed up with a U.S. veteran, Roberto Pickering, a former infantry Marine who was diagnosed as 100 percent disabled from PTSD in 2004.

Unlike thousands of post-9/11 veterans who have experienced fatal outcomes due to suicide, Pickering—after years of unsuccessful prescription drug use—found another way to deal with his PTSD. He began experimenting with marijuana about 10 years ago and since then has been helping other veterans.

Together, Sisley and Pickering launched the Battlefield Foundation, which provides emotional support, as well as important health and financial solutions, for vets.

Pickering outlined the foundation’s three-pronged approach to help veterans to the LA Weekly.

The first prong is emotional support in the way of sponsorship, popularized by Alcoholics Anonymous, for vets suffering from PTSD.

The second prong is medical support—offering non-opiate based relief through cannabis therapy.

This is where Sisley comes in: She and her colleagues at the Multidisciplinary Association for Psychedelic Studies (MAPS) received a grant from the government nearly two years ago to study cannabis as a treatment for veterans with PTSD.

Because of the notoriously low-quality weed provided by the government and grown at the University of Mississippi—the only facility approved by the National Institute on Drug Abuse (NIDA)—Pickering and Sisley applied for their own license to grow, but are still waiting.

Under the medical approach, primary goals include funding and raising money for clinical trials.

To that end, the Battlefield Foundation will have a for-profit brand that will invest profits back into the foundation for the research Sisley is overseeing.

Trials are definitely needed, says Sisley, even though veterans already understand that marijuana can help treat their PTSD.

“Some vets will say, ‘I don’t need your study, I already know it helps,’ but we need controlled trials and access to objective information, not just anecdotal reports,” Sisley explained. “That will help the veteran community more than anything.”

In that medical tests can cost millions, initially, veterans with access to medical marijuana under California law can report back to Sisley and her team about how marijuana works for them.

“The medical prong is all about the clinical trials; we’re developing a database that can be published,” said Sisley.

The third prong is economic assistance. The plan is to find veterans jobs in the marijuana industry or place them in positions at Pickering’s own farming facilities.

Pickering’s idea, he told Stars and Stripes, deals with crews of veterans working together for $20 an hour trimming marijuana buds for consumption.

“Vets are coming back from war, and now they have a war here in America to fight,” he said. “The enemy is suicide and an opioid epidemic, and these guys are getting healed in the very industry that’s eliminating that.”

Pickering added that military vets could go a step beyond and start their own profitable companies.

“This is medicine, and I want it to be treated as medicine and given to the masses,” Pickering said. “All I can say is, ‘Look at my life then, look at my life now.’ I want to make [cannabis] an option for all veterans, for all people, not just veterans. Sue [Sisley] is trying to give us that definitive scientific argument.”

0 1745

Vermont’s House of Representatives recently passed a bill that would legalize recreational marijuana. If Gov. Phil Scott, signs the law, Vermont would then take the place of the ninth state to legalize adult use of marijuana.

The passing of the bill, which was approved in a 79-66 vote Wednesday, according to Reuters, marks the first recreational marijuana measure to be approved by a state’s legislature. The other eight recreational pot states—Colorado, Washington, Oregon, California, Massachusetts, Maine, Nevada, Alaska— plus Washington D.C., introduced legal marijuana programs following public votes.

If Scott doesn’t veto the bill, starting July 2018 adults in Vermont will not only be able to consume marijuana legally but people 21 and older would be allowed to grow up to two mature marijuana plants at a time. Possession of up to one ounce of marijuana would also be legal.

A nine-person team of researchers also is commissioned to conduct a study to determine the best ways to regulate and tax sales of the plant, as well.

Nonetheless, it is unclear if Scott will sign the bill. The governor has been vocal about his stance on marijuana, telling reporters in 2016 that “right now” wasn’t the time for Vermont to be legalizing recreational pot. A spokeswoman for Scott, Rebecca Kelley, told Reuters in a statement that the governor wanted to make sure public safety and health concerns are addressed before singing the bill into law.

“On the issue of legalizing marijuana, the governor has said he is not philosophically opposed, but we must ensure certain public safety and health questions are answered,” Kelley stated.

Supporters of the bill urged the governor to move forward with the law.

“The Legislature has taken a crucial step toward ending the failed policy of marijuana prohibition. There is no rational reason to continue punishing adults for consuming a substance that is safer than alcohol,” Matt Simon, political director of the New England chapter of pro-legalization group Marijuana Policy Project (MPP), said in a statement delivered to Newsweek.

0 3179
marijuana-stocks-cannabis-globe

There are some lawmakers out there who believe the United States will legalize marijuana all across the nation within the next five-to-10 years. The only problem with this prediction is they have been spewing the same unsubstantiated blah-blah-blahs for the past two decades.

It seems that handicapping the death of prohibition in our fair land is not exactly easy to do, especially considering that the country is still mostly governed by stiff-collar conservative forces that subscribe to the opinion that marijuana legalization will bring about the demise of civil society. What’s worse is these shrews are convinced that this supposed disembowelment of the American soul will happen one child at a time… starting with yours!

However, if Congress does no drop the propaganda-laden political shenanigans and make some effort to put this long-overdue reform on the books sometime within the next 100 years, it is conceivable that the human race will literally suffer extinction before the majority of us, including our children, ever get a chance to find out what it means to live in a world where marijuana is handled no differently than alcohol.

At least that seems to be the opinion of renowned physicist Stephen Hawking, who, in a new BBC documentary called Expedition New Earth, explains the world is doomed to its untimely death if humanity fails to colonize another planet within the next several decades.

“With climate change, overdue asteroid strikes, epidemics and population growth, our own planet is increasingly precarious,” Hawking explained.

This prediction is slightly more unnerving than Hawking’s previous theory, which suggested the human race would likely be wiped out sometime within the next 1,000 years—a timeline that did not invoke much concern among that portion of the population that still lies awake at night haunted by the mysteries that come with being born.

However, for those people living with small children, the latest hypothesis indicates that the youth of today could be part of the adult population that either has to find a way to inhabit other planetary jurisdictions or be snuffed out in a manner of which is only known by the dinosaurs. And according to science, they never made a comeback.

“Although the chance of disaster to planet Earth in a given year may be quite low, it adds up over time, and becomes a near certainty in the next 1,000 or 10,000 years,” Hawking said during a lecture last November at Oxford University.

“By that time, we should have spread out into space, and to other stars, so a disaster on Earth would not mean the end of the human race,” he added. “However, we will not establish self-sustaining colonies in space for at least the next hundred years, so we have to be very careful in this period.”

Hawking advises humans to find a way to inhabit the moon or Mars as a way to evade a total catastrophe on Earth. Fortunately, there is already a legion of scientists working to put people on Mars within the next 20 years.

“I’m excited to announce that we are working with our commercial partners to build new habitats that can sustain and transport astronauts on long-duration missions in deep space,” former President Barack Obama wrote in 2016. “These missions will teach us how humans can live far from Earth—something we’ll need for the long journey to Mars.”

But then again, living on the Red Planet would be cold, dark and depressing—sort of like living in a desert, only it never gets even close to warm and there is no weed, Taco Bell or pizza delivery within 50 miles. The second coming of humanity would undoubtedly suck far worse than even the darkest days on planet Earth.

But for the sake of future generations, let’s hope that Stephen Hawking is about as accurate with his latest doomsday prediction as federal lawmakers have been about nationwide marijuana legalization.

0 3307

A new proposal before legislators in Salem is arranged to protect people who purchase cannabis in Oregon. It’s considered emergency legislation, which means that if passed, it would immediately take effect. This proposal comes after comments from the federal government about pushing back on the six states that have legalized cannabis. Back on February 24, 2017, White House press secretary Sean Spicer said, “I do believe you will see greater enforcement of it.”

When asked about medical cannabis, Spicer stated, “that is very different than recreational use, which is something the Department of Justice, I think, will be further looking into.” Currently, when you buy marijuana in Oregon, the business records your identification information to ensure you’re not purchasing more than the legal amount per day. The CEO of Cannabliss & Co. in Portland, Matt Price, says the need for minimal identification information is to ensure buyers are staying within the legal limit.

Price stated, “If I have to purge the system and come up with some crazy way to track individuals it would be easy for people to abuse those powers.” Senate Bill 863 does two things. First, cannabis dispensaries or retailers wouldn’t be able to keep anyone’s information for more than four days. Second, it would make it illegal for the retailer or dispensary to give anyone’s information to anyone else. On the bottom of the bill’s summary it states the emergency act is “necessary for the immediate preservation of the public peace, health and safety.”

Price stated, “There is a lot of fear in a new administration I think these guys are going to be a little more stringent but I don’t think they are going to be messing with any licensed legal state business.” Senator Floyd Prozanski is one of the key supporters of the bill he says the goal is to ensure voters got what they were expecting when they passed Measure 91. He says the hope would be to get the marijuana industry to be more like the alcohol industry, meaning marijuana stores check age but don’t keep consumers’ personal information.

0 1607

 

$AGSTF to Manage Cannabis Oil Extraction Facility, Also Announces $1,000,000 Non-Brokered Private Placement


Future Farm Technologies Inc. (the “Company” or “Future Farm”) (CSE: FFT) (OTCQB: AGSTF) is pleased to announce that its subsidiary, FFM Consulting Services, LLC, a California limited liability company, has entered into a management agreement with a California non-profit company. The non-profit has secured a sublicense to legally manufacture cannabis oil using a non-volatile method compliant under the Medical Marijuana Regulation And Safety Act (“MMRSA”), in South-eastern Los Angeles County, California..[continue]


Click Here To View Full Press Release



CBD Proposal Has Finally Been Approved In Wisconsin

In Wisconsin, the subject of cannabis for medicinal purposes has been nearly untouched aside from a 2014 proposal that exempted patients with seizure afflictions and a doctor’s recommendation from arrest for possessing or using CBD oil. That proposal didn’t do much to help patients with seizures and nothing to help the many other patients who would benefit from medical cannabis. This year they are making another attempt at passing a CBD proposal that would legalize the use and possession cannabidiol for patients with a doctor’s prescription.


Click Here To Read Full Article


 

Canada Legalization: The Next Big Catalyst

 

Canadian licensed medical cannabis producers built off the momentum from Wednesday and benefited from this as it carried into Thursday’s trading session.We recapped some of these recent price movements and provided our updated thesis


Click Here To View Full Article


Pursuant to an agreement between MAPH and ARCTURUS GROWTHSTAR, we were hired for a period of 30 days to publicly disseminate information about (AGSTF) including on the Website and other media including Facebook and Twitter. We are being paid $37,500 (CASH) for and were paid 1 million shares of restricted common shares. We may buy or sell additional shares of (AGSTF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. PLEASE READ OUR FULL PRIVACY POLICY & TERMS OF USE & DISCLAIMER

Subscribe Now & Begin Receiving Marijuana Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Marijuana Stocks, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on marijuana stocks related, articles, news and trade alerts. Further questions please contact privacy@marijuanastocks.com
Ad Placements